Rafael Holdings, Inc. (RFL:NYSE) closed at $1.31 on October 23, 2026, up 2.34% on the day. The stock trades 66.9% below its 52-week high of $3.96 and 17.0% above its 52-week low of $1.12. Over the past year, it lost 3.0%. Rafael Holdings, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, RFL closed higher on 112 days (44%). Its best day was June 11, 2026 (+19.10%) and its worst was September 30, 2026 (-34.98%). The stock moved 10% or more in a single session 16 times. It opened at least 5% above the previous day's high 1 time.
Rafael Holdings includes commercial real estate assets and interests in two clinical-stage pharmaceutical companies backed by a strong and liquid balance sheet. Rafael's real estate holdings are comprised by a 20-story commercial office building and associated parking garage in Newark, New Jersey, an office/data center building in Piscataway, New Jersey and an office condominium in Israel. Rafael's pharmaceutical holdings include interests in two clinical-stage oncology companies - Rafael Pharmaceuticals and LipoMedix. Rafael Pharmaceuticals is developing therapies that exploit the metabolic differences between normal cells and cancer cells in both solid and liquid cancers. LipoMedix is developing liposomal prodrugs designed to enhance the efficacy of certain chemotherapeutic therapies.
Find more stocks like RFL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.